Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT

M. Schmidt-Hieber, D. Engelhard, A. Ullmann, P. Ljungman, J. Maertens, R. Martino, M. Rovira, PJ. Shaw, C. Robin, M. Faraci, J. Byrne, K. Schäfer-Eckart, H. Einsele, E. Faber, L. Rigacci, R. Saccardi, A. Balaguer-Rosello, C. Isaksson, M....

. 2020 ; 267 (2) : 430-439. [pub] 20191029

Language English Country Germany

Document type Journal Article

E-resources Online Full text

NLK ProQuest Central from 1997-04-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-04-01 to 1 year ago

We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36%) were infections. Proven or probable infections were documented in 34 patients and included fungi (n = 10, 29%), viruses (n = 12, 35%), Toxoplasma spp. (n = 9, 27%) and bacteria (n = 3, 9%). Non-infectious neurological disorders (n = 105, 64%) frequently encompassed metabolic/drug-induced abnormalities (n = 28, 27%) or cerebral vascular events (n = 22, 21%). Median onset times were later for infectious (day + 101) vs non-infectious neurological disorders (day + 50, p = 0.009). An unremarkable cranial CT scan was found in 33% of infection episodes. Absence of cerebrospinal fluid pleocytosis despite a normal or increased peripheral blood white blood cell count occurred in 26% of infections. Day-30 mortality rates were significantly higher for fungal (87%) vs non-fungal infections (40%, p < 0.001). Significantly higher mortality rates were also documented for cerebral vascular events than for other non-infectious disorders (86% vs 34%, p < 0.001). Our prospective study shows that diagnostic findings in CNS infections might differ between hematopoietic stem cell transplant recipients and immunocompetent hosts. Special awareness and timely initiation of adequate diagnostics are crucial to improve the prognosis of these patients.

Assistance Publique Hopitaux de Paris Henri Mondor University Hospital Hematology Department and UPEC Créteil France Hôspital Henri Mondor Créteil France

Azienda Ospedaliera Universitaria Careggi Florence Italy

Clinic for Hematology and Oncology Carl Thiem Klinikum Thiemstr 111 03048 Cottbus Germany

Clinic for Hematology and Oncology Klinikum Nürnberg Paracelsus Medizinische Privatuniversität Nürnberg Germany

Department of Hemato Oncology Faculty Hospital Olomouc Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic

Department of Hematology Institute of Hematology and Oncology IDIBAPS Hospital Clinic University of Barcelona Josep Carreras Leukemia Research Institute Barcelona Spain

Department of Internal Medicine 2 University Hospital Würzburg Würzburg Germany

Department of Microbiology Immunology and Transplantation KU Leuven Leuven Belgium

Department of Pediatric Hematology and Oncology Collegium Medicum UMK Bydgoszcz Poland

Department of Pediatrics Hadassah Hebrew University Medical Center Jerusalem Israel

Department of Stem Cell Transplantation University Medical Center Eppendorf Hamburg Germany

Division of Infectious Diseases University of Genova DISSAL Genoa Italy IRCCS Ospedale Policlinico San Martino Genoa Italy

EBMT Data Office Leiden The Netherlands

Hematopoietic Stem Cell Unit Transplantation IRCCS Instituto G Gaslini Genova Italy

Hospital de la Santa Creu i Sant Pau Autonomous University of Barcelona Barcelona Spain

Hospital Universitari 1 Politècnic La Fe Valencia Spain

Karolinska University Hospital and Karolinska Institutet Stockholm Sweden

Nottingham University Hospital Nottingham UK

Ospedale S Camillo Rome Italy

Pediatric Hematology Oncology Mother and Child Hospital Azienda Ospedaliera Universitaria Integrata Verona Italy

Pediatric Hematology Oncology Mother and Child Hospital Azienda Ospedaliera Universitaria Integrata Verona Italy EBMT Data Office Leiden The Netherlands

The Children's Hospital at Westmead Sydney Australia

Umea University Hospital Umeå Sweden

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028561
003      
CZ-PrNML
005      
20210114154249.0
007      
ta
008      
210105s2020 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00415-019-09578-5 $2 doi
035    __
$a (PubMed)31664549
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Schmidt-Hieber, Martin $u Clinic for Hematology and Oncology, Carl-Thiem-Klinikum, Thiemstr. 111, 03048, Cottbus, Germany. m.schmidt_hieber@ctk.de.
245    10
$a Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT / $c M. Schmidt-Hieber, D. Engelhard, A. Ullmann, P. Ljungman, J. Maertens, R. Martino, M. Rovira, PJ. Shaw, C. Robin, M. Faraci, J. Byrne, K. Schäfer-Eckart, H. Einsele, E. Faber, L. Rigacci, R. Saccardi, A. Balaguer-Rosello, C. Isaksson, M. Christopeit, G. Tridello, J. Wang, N. Knelange, M. Mikulska, S. Cesaro, J. Styczynski,
520    9_
$a We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36%) were infections. Proven or probable infections were documented in 34 patients and included fungi (n = 10, 29%), viruses (n = 12, 35%), Toxoplasma spp. (n = 9, 27%) and bacteria (n = 3, 9%). Non-infectious neurological disorders (n = 105, 64%) frequently encompassed metabolic/drug-induced abnormalities (n = 28, 27%) or cerebral vascular events (n = 22, 21%). Median onset times were later for infectious (day + 101) vs non-infectious neurological disorders (day + 50, p = 0.009). An unremarkable cranial CT scan was found in 33% of infection episodes. Absence of cerebrospinal fluid pleocytosis despite a normal or increased peripheral blood white blood cell count occurred in 26% of infections. Day-30 mortality rates were significantly higher for fungal (87%) vs non-fungal infections (40%, p < 0.001). Significantly higher mortality rates were also documented for cerebral vascular events than for other non-infectious disorders (86% vs 34%, p < 0.001). Our prospective study shows that diagnostic findings in CNS infections might differ between hematopoietic stem cell transplant recipients and immunocompetent hosts. Special awareness and timely initiation of adequate diagnostics are crucial to improve the prognosis of these patients.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a infekce centrálního nervového systému $x epidemiologie $x etiologie $7 D002494
650    _2
$a cerebrovaskulární poruchy $x epidemiologie $x etiologie $7 D002561
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a transplantace hematopoetických kmenových buněk $x škodlivé účinky $x statistika a číselné údaje $7 D018380
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Engelhard, Dan $u Department of Pediatrics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
700    1_
$a Ullmann, Andrew $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
700    1_
$a Ljungman, Per $u Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Maertens, Johan $u Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.
700    1_
$a Martino, Rodrigo $u Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
700    1_
$a Rovira, Montserrat $u Department of Hematology, Institute of Hematology and Oncology, IDIBAPS, Hospital Clinic, University of Barcelona, Josep Carreras Leukemia Research Institute, Barcelona, Spain.
700    1_
$a Shaw, Peter J $u The Children's Hospital at Westmead, Sydney, Australia.
700    1_
$a Robin, Christine $u Assistance Publique-Hopitaux de Paris, Henri Mondor University Hospital, Hematology Department and UPEC, Créteil France Hôspital Henri Mondor, Créteil, France.
700    1_
$a Faraci, Maura $u Hematopoietic Stem Cell Unit Transplantation, IRCCS Instituto G. Gaslini, Genova, Italy.
700    1_
$a Byrne, Jenny $u Nottingham University Hospital, Nottingham, UK.
700    1_
$a Schäfer-Eckart, Kerstin $u Clinic for Hematology and Oncology, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Nürnberg, Germany.
700    1_
$a Einsele, Hermann $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
700    1_
$a Faber, Edgar $u Department of Hemato-Oncology, Faculty Hospital Olomouc, Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic.
700    1_
$a Rigacci, Luigi $u Ospedale S. Camillo, Rome, Italy.
700    1_
$a Saccardi, Riccardo $u Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
700    1_
$a Balaguer-Rosello, Aitana $u Hospital Universitari I Politècnic La Fe, Valencia, Spain.
700    1_
$a Isaksson, Cecilia $u Umea University Hospital, Umeå, Sweden.
700    1_
$a Christopeit, Maximilian $u Department of Stem Cell Transplantation, University Medical Center Eppendorf, Hamburg, Germany.
700    1_
$a Tridello, Gloria $u Pediatric Hematology Oncology, Mother and Child Hospital, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. EBMT Data Office, Leiden, The Netherlands.
700    1_
$a Wang, Junfeng $u EBMT Data Office, Leiden, The Netherlands.
700    1_
$a Knelange, Nina $u EBMT Data Office, Leiden, The Netherlands.
700    1_
$a Mikulska, Malgorzata $u Division of Infectious Diseases, University of Genova, DISSAL, Genoa, Italy. IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
700    1_
$a Cesaro, Simone $u Pediatric Hematology Oncology, Mother and Child Hospital, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
700    1_
$a Styczynski, Jan $u Department of Pediatric Hematology and Oncology, Collegium Medicum UMK, Bydgoszcz, Poland.
773    0_
$w MED00002835 $t Journal of neurology $x 1432-1459 $g Roč. 267, č. 2 (2020), s. 430-439
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31664549 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154245 $b ABA008
999    __
$a ok $b bmc $g 1608896 $s 1119741
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 267 $c 2 $d 430-439 $e 20191029 $i 1432-1459 $m Journal of neurology $n J Neurol $x MED00002835
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...